182 related articles for article (PubMed ID: 30685498)
1. Monitoring treatment response in chronic pulmonary aspergillosis: role of clinical, spirometric and immunological markers.
Sehgal IS; Dhooria S; Choudhary H; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
Clin Microbiol Infect; 2019 Sep; 25(9):1157.e1-1157.e7. PubMed ID: 30685498
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic cut-off of Aspergillus fumigatus-specific IgG in the diagnosis of chronic pulmonary aspergillosis.
Sehgal IS; Choudhary H; Dhooria S; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
Mycoses; 2018 Oct; 61(10):770-776. PubMed ID: 29920796
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of A fumigatus-specific IgG and galactomannan testing in the diagnosis of simple aspergilloma.
Sehgal IS; Dhooria S; Choudhary H; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
Mycoses; 2019 Dec; 62(12):1108-1115. PubMed ID: 31408547
[TBL] [Abstract][Full Text] [Related]
4. Impact of high baseline Aspergillus-specific IgG levels on weight and quality-of-life outcomes of patients with chronic pulmonary aspergillosis.
Bongomin F; Garcez T; Denning DW
Med Mycol; 2020 Oct; 58(7):1000-1004. PubMed ID: 32343313
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic cut-off value for Aspergillus fumigatus- and flavus-specific IgG with clinical relevance in chronic pulmonary Aspergillus infection: A pilot study in Taiwan.
Huang SF; Li SY; Chan YJ; Huang YC; Yang YY; Wang FD
Mycoses; 2020 Oct; 63(10):1083-1093. PubMed ID: 32677131
[TBL] [Abstract][Full Text] [Related]
6. Prospective study of the serum Aspergillus-specific IgG, IgA and IgM assays for chronic pulmonary aspergillosis diagnosis.
Ma X; Wang K; Zhao X; Liu Y; Li Y; Yu X; Li C; Denning DW; Xie L
BMC Infect Dis; 2019 Aug; 19(1):694. PubMed ID: 31387539
[TBL] [Abstract][Full Text] [Related]
7. Pulsed echinocandin therapy in azole intolerant or multiresistant chronic pulmonary aspergillosis: A retrospective review at a UK tertiary centre.
Osborne W; Fernandes M; Brooks S; Grist E; Sayer C; Hansell DM; Wilson R; Shah A; Loebinger MR
Clin Respir J; 2020 Jun; 14(6):571-577. PubMed ID: 32077238
[TBL] [Abstract][Full Text] [Related]
8. Gastroesophageal Reflux Disease and Pulmonary Diseases Associated with Aspergillosis: Is There a Connection?
Gamaletsou MN; Denning DW
Mycopathologia; 2017 Dec; 182(11-12):1125-1129. PubMed ID: 28702854
[TBL] [Abstract][Full Text] [Related]
9. Is There an Overlap in Immune Response Between Allergic Bronchopulmonary and Chronic Pulmonary Aspergillosis?
Sehgal IS; Choudhary H; Dhooria S; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
J Allergy Clin Immunol Pract; 2019 Mar; 7(3):969-974. PubMed ID: 30205191
[TBL] [Abstract][Full Text] [Related]
10. Utility of Serum and Bronchoalveolar Lavage Fluid Galactomannan in Diagnosis of Chronic Pulmonary Aspergillosis.
Sehgal IS; Dhooria S; Choudhary H; Aggarwal AN; Garg M; Chakrabarti A; Agarwal R
J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30626661
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of Aspergillus IgG and disease prevalence of chronic pulmonary aspergillosis in a country with intermediate burden of tuberculosis: a prospective observational study.
Lee MR; Huang HL; Chen LC; Yang HC; Ko JC; Cheng MH; Chong IW; Lee LN; Wang JY; Dimopoulos G
Clin Microbiol Infect; 2020 Aug; 26(8):1091.e1-1091.e7. PubMed ID: 31901491
[TBL] [Abstract][Full Text] [Related]
12. Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.
Evans TJ; Lawal A; Kosmidis C; Denning DW
Semin Respir Crit Care Med; 2024 Feb; 45(1):88-101. PubMed ID: 38154471
[TBL] [Abstract][Full Text] [Related]
13. Comparative performance of Aspergillus galactomannan ELISA and PCR in sputum from patients with ABPA and CPA.
Fayemiwo S; Moore CB; Foden P; Denning DW; Richardson MD
J Microbiol Methods; 2017 Sep; 140():32-39. PubMed ID: 28645480
[TBL] [Abstract][Full Text] [Related]
14. [Aspergillus in airway material : Ignore or treat?].
Salzer HJF; Lange C; Hönigl M
Internist (Berl); 2017 Nov; 58(11):1150-1162. PubMed ID: 28986661
[TBL] [Abstract][Full Text] [Related]
15. Serum Aspergillus fumigatus-specific IgG antibody decreases after antifungal treatment in chronic pulmonary aspergillosis patients.
Yao Y; Zhou H; Yang Q; Lu G; Yu Y; Shen Y; Zhou J
Clin Respir J; 2018 Apr; 12(4):1772-1774. PubMed ID: 28862383
[No Abstract] [Full Text] [Related]
16. Comparison of six Aspergillus-specific IgG assays for the diagnosis of chronic pulmonary aspergillosis (CPA).
Page ID; Richardson MD; Denning DW
J Infect; 2016 Feb; 72(2):240-9. PubMed ID: 26680697
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of generic forms of itraconazole capsule in treating subjects with chronic pulmonary aspergillosis.
Sehgal IS; Vinay K; Dhooria S; Muthu V; Prasad KT; Aggarwal AN; Chakrabarti A; Rudramurthy SM; Choudhary H; Agarwal R
Mycoses; 2023 Jul; 66(7):576-584. PubMed ID: 36967117
[TBL] [Abstract][Full Text] [Related]
18. Predictive factors for treatment response and mortality in chronic pulmonary aspergillosis.
Kosmidis C; Smith H; Mollett G; Harris C; Akili S; Bazaz R
Mycoses; 2023 Nov; 66(11):960-968. PubMed ID: 37553558
[TBL] [Abstract][Full Text] [Related]
19. Siemens Immulite Aspergillus-specific IgG assay for chronic pulmonary aspergillosis diagnosis.
Page ID; Richardson MD; Denning DW
Med Mycol; 2019 Apr; 57(3):300-307. PubMed ID: 29762749
[TBL] [Abstract][Full Text] [Related]
20. Management of chronic pulmonary aspergillosis.
Izumikawa K; Tashiro M; Kohno S
Ann N Y Acad Sci; 2012 Dec; 1272():40-8. PubMed ID: 23231713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
